A.R.T. Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,300
Closed -$16K 1962
2017
Q1
$16K Sell
14,300
-2,100
-13% -$2.73K ﹤0.01% 1379
2016
Q4
$20K Buy
+16,400
New +$30.3K ﹤0.01% 1245

Other funds holding WINT

A.R.T. Advisors's WINT Position: Q2 2017 in Review

A.R.T. Advisors sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 14,300 shares — an estimated $16K sold.

A.R.T. Advisors first reported a position in WINT in Q4 2016 and held it in 2 quarters. The position peaked at $20K in Q4 2016. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • A.R.T. Advisors reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 14,300 Windtree Therapeutics Inc shares in Q2 2017, an estimated $16K.
  • A.R.T. Advisors first reported a position in Windtree Therapeutics Inc in Q4 2016 and held it in 2 quarters.
  • A.R.T. Advisors's Windtree Therapeutics Inc position peaked at $20K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.